Gene: SLC27A6
Official Full Name: solute carrier family 27 member 6provided by HGNC
Gene Summary: This gene encodes a member of the fatty acid transport protein family (FATP). FATPs are involved in the uptake of long-chain fatty acids and have unique expression patterns. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27294 | SLC27A6 Knockout cell line (HCT 116) | Human | SLC27A6 | 1:2~1:4 | Negative | Online Inquiry |
SLC27A6 Gene Knockout Cell Lines are genetically modified cellular models specifically designed to lack the SLC27A6 gene, which encodes a fatty acid transporter involved in the uptake of long-chain fatty acids into cells. These knockout cell lines are invaluable tools for researchers studying metabolic pathways, particularly those related to lipid metabolism, cell signaling, and energy homeostasis.
The primary function of SLC27A6 is to facilitate the translocation of fatty acids across cellular membranes, impacting various physiological processes such as energy production and membrane synthesis. By creating knockout models that entirely eliminate SLC27A6, researchers can examine the downstream effects of disrupted fatty acid transport. These cell lines enable a detailed investigation of altered lipid profiles, cellular responses to nutrient availability, and the role of fatty acids in disease models, such as obesity, metabolic syndrome, and cardiovascular diseases.
In the scientific community, SLC27A6 Gene Knockout Cell Lines hold significant relevance for both fundamental research and clinical applications. They provide a reliable platform for drug development targeting lipid-related disorders, as well as for further elucidating the role of fatty acids in signal transduction and gene expression. Additionally, these knockout models allow researchers to assess compensatory metabolic pathways, shedding light on intricate biological interactions.
Compared to traditional cell lines, SLC27A6 knockout versions offer distinct advantages, including precise control over fatty acid availability and the ability to mimic human physiology more closely when studying lipid-related phenotypes. Their specificity minimizes off-target effects seen with pharmacological inhibitors, contributing to more reproducible experimental outcomes.
For researchers and clinicians focused on metabolic diseases or lipidology, SLC27A6 Gene Knockout Cell Lines present a unique opportunity to explore new therapeutic strategies and deepen our understanding of fatty acid metabolism. Investing in these advanced cell models can enrich research outcomes and accelerate progress in the development of targeted treatments.
Our company specializes in high-quality biological products designed to support the needs of the scientific community, ensuring that researchers have access to reliable tools that can propel their work forward. With years of expertise in genetic engineering and cell culture technology, we are committed to providing innovative solutions that elevate research standards in the field of biosciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.